Tuesday, February 3, 2026

Fosun Pharma subsidiary signs potential $1.9bn Pfizer licence deal


Chongqing Yao Pharmaceutical Company (Yao Pharma) and Shanghai Fosun Pharmaceutical Industrial Development Company, both subsidiaries of Fosun Pharma, have entered into an exclusive collaboration and licence agreement with US pharmaceutical giant Pfizer, according to a December announcement.



¬ Haymarket Media Limited. All rights reserved.







Source link

Speak Your Mind

*


*